Brown Advisory’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
Brown Advisory's RARE Position: Q4 2018 in Review
Brown Advisory sold out of Ultragenyx Pharmaceutical (RARE) in Q4 2018, closing a stake of 226,734 shares — an estimated $17.3M sold.
Brown Advisory first reported a position in RARE in Q1 2014 and held it in 19 quarters. The position peaked at $31M in Q2 2018. 164 funds tracked by Wall St. Rank hold RARE as of Q4 2018.
- Brown Advisory reported no remaining Ultragenyx Pharmaceutical position as of Q4 2018 after selling out during the quarter.
- Brown Advisory sold 226,734 Ultragenyx Pharmaceutical shares in Q4 2018, an estimated $17.3M.
- Brown Advisory first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and held it in 19 quarters.
- Brown Advisory's Ultragenyx Pharmaceutical position peaked at $31M in Q2 2018.
- 164 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2018.
Based on Brown Advisory's 13F filing for Q4 2018, filed 13 Feb 2019.